EVENT RESOURCES
- Wednesday, September 4, 2024
- Thursday, September 5, 2024
- Friday, September 6, 2024
- Saturday, September 7, 2024
| Name | Time | Virtual Session Link |
|---|---|---|
| Session I: Acute Lymphoblastic Leukemia | 9:00 AM - 11:36 AM | Go To Session |
| Plenary Session I | 12:56 PM - 1:16 PM | Go To Session |
| Session II: Myelodysplastic Syndromes | 1:16 PM - 2:56 PM | Go To Session |
| Session III: Acute Myeloid Leukemia | 3:26 PM - 6:00 PM | Go To Session |
| Name | Time | Virtual Session Link |
|---|---|---|
| Session IV: Chronic Myeloid Leukemia | 8:00 AM - 9:40 AM | Go To Session |
| Session V: MyeloproliferatIVe Neoplasms | 10:10 AM - 11:50 AM | Go To Session |
| Plenary Session II | 1:20 PM - 1:40 PM | Go To Session |
| Session VI: Multiple Myeloma | 1:40 PM - 3:56 PM | Go To Session |
| Session VII: Chronic Lymphocytic Leukemia | 4:26 PM - 6:24 PM | Go To Session |
| Name | Time | Virtual Session Link |
|---|---|---|
| Session VIII: T-Cell Lymphoma | 8:00 AM - 9:40 AM | Go To Session |
| Session IX: Indolent B-Cell Lymphoma | 10:10 AM - 11:42 AM | Go To Session |
| Plenary Session III | 1:07 PM - 1:27 PM | Go To Session |
| Session X: Aggressive B-Cell Lymphoma | 1:27 PM - 3:35 PM | Go To Session |
| Session XI: Mantle Cell Lymphoma | 4:05 PM - 5:17 PM | Go To Session |
| Session XII: Hodgkin Lymphoma | 5:17 PM - 5:53 PM | Go To Session |
| Name | Time | Virtual Session Link |
|---|---|---|
| Session XIII: Cellular therapy | 8:00 AM - 9:01 AM | Go To Session |
| Session XIV: Next Questions | 9:36 AM - 11:56 PM | Go To Session |
Time Zone: (UTC-06:00) Central Time (US & Canada) [Change Time Zone]
Time Zone: (UTC-06:00) Central Time (US & Canada) [Change Time Zone]
Dr. Thomas James Kipps MD, PhD
UC San Diego Moores Cancer Center
Director, Center for Novel Therapeutics
UC San Diego Moores Cancer Center
Director, Center for Novel Therapeutics
Dr. Michael Deininger MD, PhD
Versiti Blood Research Institute
Executive Vice President and Chief Scientific Officer
Versiti Blood Research Institute
Executive Vice President and Chief Scientific Officer
Dr. David Scott MBChB, PhD
University of British Columbia
Deputy Head at Department of Lymphoid Cancer Research, Clinical Director at Centre for Lymphoid Cancer and Associate Professor at Faculty of Medicine
University of British Columbia
Deputy Head at Department of Lymphoid Cancer Research, Clinical Director at Centre for Lymphoid Cancer and Associate Professor at Faculty of Medicine
Dr. Eliza Hawkes MBBS Hons, FRACP, DMedSc
Olivia Newton-John Cancer Research Institute at Austin Health
Associate Professor, Lymphoma Lead, Department Clinical Haematology & Medical Oncology
Olivia Newton-John Cancer Research Institute at Austin Health
Associate Professor, Lymphoma Lead, Department Clinical Haematology & Medical Oncology
Dr. Christopher Flowers MD, MS, FASCO
MD Anderson Cancer Center
Department Chair, Department of Lymphoma/Myeloma
MD Anderson Cancer Center
Department Chair, Department of Lymphoma/Myeloma
